Characteristic . | Total cohort . | Treatment group . | Age categories . | |||
---|---|---|---|---|---|---|
INT . | CONV . | ≤35 years . | 36–50 years . | 51–65 years . | ||
n | 1,177 | 599 | 578 | 59 | 693 | 425 |
VPT great toe | 3.78 ± 2.35 | 3.53 ± 2.19 | 4.03 ± 2.47† | 2.38 ± 1.61 | 3.44 ± 1.97 | 4.53 ± 2.75† |
Abnormal | 710 (61) | 341 (57) | 369 (64)* | 20 (34) | 401 (58) | 289 (69)† |
VPT index finger | 1.05 ± 0.51 | 0.99 ± 0.42 | 1.11 ± 0.58† | 0.96 ± 0.42 | 1.00 ± 0.47 | 1.13 ± 0.58† |
Abnormal | 71 (6) | 24 (4) | 47 (8)† | 2 (3) | 41 (6) | 28 (7) |
Characteristic . | Total cohort . | Treatment group . | Age categories . | |||
---|---|---|---|---|---|---|
INT . | CONV . | ≤35 years . | 36–50 years . | 51–65 years . | ||
n | 1,177 | 599 | 578 | 59 | 693 | 425 |
VPT great toe | 3.78 ± 2.35 | 3.53 ± 2.19 | 4.03 ± 2.47† | 2.38 ± 1.61 | 3.44 ± 1.97 | 4.53 ± 2.75† |
Abnormal | 710 (61) | 341 (57) | 369 (64)* | 20 (34) | 401 (58) | 289 (69)† |
VPT index finger | 1.05 ± 0.51 | 0.99 ± 0.42 | 1.11 ± 0.58† | 0.96 ± 0.42 | 1.00 ± 0.47 | 1.13 ± 0.58† |
Abnormal | 71 (6) | 24 (4) | 47 (8)† | 2 (3) | 41 (6) | 28 (7) |
Data are means ± SD vibration units or n (%).
*P < 0.05;
†P < 0.01for treatment group or age-group differences by the Wilcoxon rank sum test or contingency χ2 test.